Menu
Recruiting NCT05880407

Pilot Study of Percutaneous Correction of Hallux Valgus

No phase Interventional Hallux Valgus

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: SERI osteotomy, percutaneous osteotomy according to Chevron.
Who it may be relevant to
Registry conditions: Hallux Valgus. Basic parameters: 18 years — 65 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Italy
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Pilot Study of Percutaneous Correction of Hallux Valgus: Clinical-functional Evaluation of Outcome Randomized Study

Overview

This is a pilot study with a randomized controlled design.

Interventions

  • Procedure SERI osteotomy
    Correction of varus deformity of the 1st Metatarsal that is stabilized with Kirschnner wire
  • Procedure percutaneous osteotomy according to Chevron
    Correction of varus deformity by osteotomy stabilization with 2 screws inserted via dorsal percutaneous accesses to the 1st Metatarsal.

Primary outcome measures

  • Visual Analog Score [Time frame: baseline]
  • Visual Analog Score [Time frame: 1 year]
Secondary outcome measures (1)
  • American Orhtopaedic Foot and Ankle Society forefoot score [Time frame: baseline and aftef 1 year]

Eligibility criteria

Inclusion criteria

  • Patients of both sexes with adult hallux valgus with indication for corrective surgical treatment
  • HVA (hallux valgus angle): 20°-40°
  • IMA (intermetatarsal angle): 10°-20°

Exclusion criteria

  • Patients with instability of the first metatarsophalangeal joint
  • Patients with severe morphostructural alterations or other pathologies in the foot and lower limb
  • patients requiring additional surgical procedures
  • patients with severe vascular and neurological systemic pathologies
  • systemic pathologies that may impair bone consolidation

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Open label
Primary purpose
Treatment

Study locations

Italy · 1 center
  • Istituto Ortopedico Rizzoli — Bologna

Identifiers

NCT: NCT05880407 · hallux valgus

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗